• OPEN AN ACCOUNT
Indian Indices
Nifty
25,019.80 -42.30
(-0.17%)
Sensex
82,059.42 -271.17
( -0.33%)
Bank Nifty
55,354.90 -0.70
( 0.00%)
Nifty IT
37,972.35 -321.45
( -0.84%)
Global Indices
Nasdaq
42,674.05 330.30
(0.78%)
Dow Jones
5,978.97 41.04
(0.69%)
Hang Seng
37,507.31 -246.41
(-0.65%)
Nikkei 225
8,684.56 50.81
(0.59%)
Forex
USD-INR
85.50 0.17
(0.19%)
EUR-INR
95.69 0.13
(0.13%)
GBP-INR
113.61 0.11
(0.10%)
JPY-INR
0.59 0.00
(0.74%)

EQUITY - MARKET SCREENER

Ind-Swift Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524652
INE788B01028
-121.5689814
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
INDSWFTLTD
1.24
79.73
EPS(TTM)
Face Value()
Div & Yield %
11.89
2
0
 

ur sugar industries ltd
Hikal consolidated net profit rises 48.08% in the March 2025 quarter
May 14,2025
Net profit of Hikal rose 48.08% to Rs 50.20 crore in the quarter ended March 2025 as against Rs 33.90 crore during the previous quarter ended March 2024. Sales rose 7.25% to Rs 550.00 crore in the quarter ended March 2025 as against Rs 512.80 crore during the previous quarter ended March 2024.

For the full year,net profit rose 30.46% to Rs 90.80 crore in the year ended March 2025 as against Rs 69.60 crore during the previous year ended March 2024. Sales rose 4.23% to Rs 1843.50 crore in the year ended March 2025 as against Rs 1768.70 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales550.00512.80 7 1843.501768.70 4
OPM %22.4418.41 -17.8115.10 -
PBDT106.0079.60 33 258.20213.10 21
PBT68.3047.30 44 123.8095.50 30
NP50.2033.90 48 90.8069.60 30